Categories Earnings, Finance

KeyCorp falls short of street estimates in Q1

Bank Holding company KeyCorp (NYSE: KEY) reported worse-than-expected revenue and earnings for the first quarter of 2019. Total revenues declined 2% to $1.52 billion compared to the same period last year. Net income attributable to common shareholders fell to $386 million, or $0.38 per share, from $402 million, or $0.38 per share, in the prior-year period.

Analysts were expecting earnings of 42 cents per share on revenues of $1.59 billion.

keycorp Q1 2019 earnings inforgraphic

CEO Beth Mooney said, “We continued to execute against our continuous improvement plans across the company, driving a meaningful reduction in our expenses, down 7%, excluding notable items, from the year-ago period.”

KeyCorp shares ended its last trading session 1% higher on Wednesday. The stock has gained 14% since the beginning of this year.

Taxable-equivalent net interest income grew 3.5% to $985 million, reflecting benefits from higher interest rates and higher earning asset balances. Noninterest income, meanwhile dropped 11% to $536 million.

Average loans grew 3.1% to $89.6 billion from last year while average deposits rose 5% to $107.6 billion. The growth in average loans reflected broad-based growth in commercial and industrial loans and the growth in average deposits reflected growth in higher-yielding deposit products along with strength in the retail banking franchise and growth from commercial relationships.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top